Peter Olagunju
Chief Technical Officer, TCR2 THERAPEUTICS INC.
Companies
- TCR2 THERAPEUTICS INC.Chief operating officer Jun 1, 2023 to Jun 1, 20231
- TCR2 THERAPEUTICS INC.Chief Technical Officer Jul 27, 2021 to Dec 19, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- TCR2 THERAPEUTICS INC.0 shares3Jun 1, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 1, 2023Returned to company 24,092 shares of TCR2 THERAPEUTICS INC.3
- Dec 13, 2022Sold 1,659 shares at $1.07 of TCR2 THERAPEUTICS INC.4
- Dec 12, 2022Sold 1,610 shares at $1.10 of TCR2 THERAPEUTICS INC.4
- Dec 9, 2022Sold 1,561 shares at $1.13 of TCR2 THERAPEUTICS INC.4
- Dec 8, 2022Sold 1,410 shares at $1.25 of TCR2 THERAPEUTICS INC.5
- Dec 7, 2022Sold 1,378 shares at $1.28 of TCR2 THERAPEUTICS INC.5
- Dec 6, 2022Sold 1,327 shares at $1.33 of TCR2 THERAPEUTICS INC.6
- Dec 5, 2022Sold 1,291 shares at $1.37 of TCR2 THERAPEUTICS INC.6
- Dec 2, 2022Sold 1,273 shares at $1.39 of TCR2 THERAPEUTICS INC.7
- Dec 1, 2022Exercised options 33,409 shares of TCR2 THERAPEUTICS INC.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Dec 13, 2022
- 5SEC EDGARForm 4 filed Dec 9, 2022
- 6SEC EDGARForm 4 filed Dec 7, 2022
- 7SEC EDGARForm 4 filed Dec 5, 2022